{
    "Trade/Device Name(s)": [
        "Fastect\u00ae II BUP Drug Screen Dipstick",
        "QuickTox\u00ae Drug Screen Dipcard"
    ],
    "Submitter Information": "Branan Medical Corporation",
    "510(k) Number": "K082508",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG"
    ],
    "Summary Letter Date": "November 21, 2008",
    "Summary Letter Received Date": "September 2, 2008",
    "Submission Date": "August 25, 2008",
    "Regulation Number(s)": [
        "21CFR862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Competitive immunoassay"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Dipstick",
        "Dipcard"
    ],
    "Document Summary": "FDA 510(k) summary for Fastect II BUP Drug Screen Dipstick and QuickTox Drug Screen Dipcard for qualitative detection of Buprenorphine in urine using immunochromatographic assay",
    "Indications for Use Summary": "Rapid immunochromatographic assays for qualitative detection of Buprenorphine in human urine at 10 ng/mL cutoff, intended for professional use only as a screening device with positive results requiring confirmation by alternate methods",
    "fda_folder": "Toxicology"
}